Proteotranscriptomic Profiling of 231-BR Breast Cancer Cells: Identification of Potential Biomarkers and Therapeutic Targets for Brain Metastasis-Reference-Cited by-同舟云学术

Proteotranscriptomic Profiling of 231-BR Breast Cancer Cells: Identification of Potential Biomarkers and Therapeutic Targets for Brain Metastasis

Published:2015-09 Issue:9 Volume:14 Page:2316-2330
ISSN:1535-9476
Container-title:Molecular & Cellular Proteomics
language:en
Short-container-title:Molecular & Cellular Proteomics

Author:

Dun Matthew D.,Chalkley Robert J.,Faulkner Sam,Keene Sheridan,Avery-Kiejda Kelly A.,Scott Rodney J.,Falkenby Lasse G.,Cairns Murray J.,Larsen Martin R.,Bradshaw Ralph A.,Hondermarck Hubert

Funder

National Institutes of Health

Publisher

Elsevier BV

Subject

Molecular Biology,Biochemistry,Analytical Chemistry

Reference77 articles.

1. Epidemiology of brain metastases;Nayak;Curr. Oncol. Reports,2012

2. The biology of brain metastases-translation to new therapies;Eichler;Nature Rev. Clin. Oncol,2011

3. Brain metastasis: New opportunities to tackle therapeutic resistance;Seoane;Mol. Oncol,2014

4. Brain metastases of breast cancer;Palmieri;Breast Disease,2006

5. Strategies for the discovery and development of therapies for metastatic breast cancer;Eckhardt;Nat. Rev. Drug Discov,2012

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumor-derived mesenchymal progenitor cell-related genes in the regulation of breast cancer proliferation;Gland Surgery;2024-03

2. Molecular signaling network and therapeutic developments in breast cancer brain metastasis;Advances in Cancer Biology - Metastasis;2023-07

3. Aminosteroid RM-581 Decreases Cell Proliferation of All Breast Cancer Molecular Subtypes, Alone and in Combination with Breast Cancer Treatments;Journal of Clinical Medicine;2023-06-24

4. PI3K/mTOR is a therapeutically targetable genetic dependency in diffuse intrinsic pontine glioma;2023-04-17

5. Blockade of ROS production inhibits oncogenic signaling in acute myeloid leukemia and amplifies response to precision therapies;Science Signaling;2023-03-28